POPULARITY
7 episodes with consultant medical oncologist
4 episodes with consultant medical oncologist
4 episodes with consultant medical oncologist
2 episodes with consultant medical oncologist
2 episodes with consultant medical oncologist
2 episodes with consultant medical oncologist
2 episodes with consultant medical oncologist
4 episodes with consultant medical oncologist
2 episodes with consultant medical oncologist
Professor Janice Walshe, Consultant Medical Oncologist, St Vincent's University Hospital and Neil McDonnell, CEO of the ISME, who represents Small and Medium businesses
In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Janice Walshe, Consultant Medical Oncologist at St Vincent's University Hospital, Dublin, Ireland. They explore the economic realities of cancer diagnostics, fertility preservation in patients with breast cancer, and the impact of international collaboration on the future of clinical trials. Timestamps: 00:00 – Introduction 03:25 – Economic disparities and oncology care in Ireland 07:20 – Neoadjuvant therapy for HER2-positive breast cancer 10:13 – Spotlight on invasive lobular carcinoma 12:36 – Fertility preservation in breast cancer 15:20 – Menopause after cancer 19:09 – The latest clinical trials in Ireland 21:50 – International trials and research projects 23:50 – Walshe's three wishes for healthcare
‘Tanning TikTok' has seen a resurgence of the use of sunbeds among Gen Z despite well-known health risks.Professor Seamus O'Reilly, Consultant Medical Oncologist in Cork University Hospital joins Ciara for NewsTalk Breakfast to go through this shocking resurgence.
‘Tanning TikTok' has seen a resurgence of the use of sunbeds among Gen Z despite well-known health risks.Professor Seamus O'Reilly, Consultant Medical Oncologist in Cork University Hospital joins Ciara for NewsTalk Breakfast to go through this shocking resurgence.
Dr. Michael McCarthy, Secretary of the Irish Society of Medical Oncology and Consultant Medical Oncologist and Professor Michael Barry, Clinical Director for the National Centre for Pharmacoeconomics
Breast cancer diagnoses and deaths will surge worldwide by 2050, according to the World Health Organisation. Jonathan discusses the projection with Professor Janice Walshe, Consultant Medical Oncologist at St. Vincent's University Hospital.
Breast cancer diagnoses and deaths will surge worldwide by 2050, according to the World Health Organisation. Jonathan discusses the projection with Professor Janice Walshe, Consultant Medical Oncologist at St. Vincent's University Hospital.
Oesophageal cancer affects more men than women in Ireland by a wide gap. But according to a recent survey from the Oesophageal Cancer Fund, a third of men are still unaware of its symptoms. Joining Shane this morning on the show was Dr Michael McCarthy, Consultant Medical Oncologist, Secretary of the Irish Society of Medical Oncology.
Oesophageal cancer affects more men than women in Ireland by a wide gap. But according to a recent survey from the Oesophageal Cancer Fund, a third of men are still unaware of its symptoms. Joining Shane this morning on the show was Dr Michael McCarthy, Consultant Medical Oncologist, Secretary of the Irish Society of Medical Oncology.
Ireland's midwest has the lowest survival rate for cancers, that's according to the latest National Cancer Registry report. We discuss these findings with Dr Michael McCarthy, Consultant Medical Oncologist, Secretary of the Irish society of Medical Oncology.
Ireland's midwest has the lowest survival rate for cancers, that's according to the latest National Cancer Registry report. We discuss these findings with Dr Michael McCarthy, Consultant Medical Oncologist, Secretary of the Irish society of Medical Oncology.
Hospitals are famously wasteful places, with many things necessarily being thrown out. In fact, 20% of medical care is waste, from plastic biohazard buckets to glass vials. So, how can this change in order to help the climate crisis?Joining Seán to discuss is Professor Seamus O'Reilly, Consultant Medical Oncologist in Cork University Hospital, who has been carrying out research in this area…
Hospitals are famously wasteful places, with many things necessarily being thrown out. In fact, 20% of medical care is waste, from plastic biohazard buckets to glass vials. So, how can this change in order to help the climate crisis?Joining Seán to discuss is Professor Seamus O'Reilly, Consultant Medical Oncologist in Cork University Hospital, who has been carrying out research in this area…
A €4.9 million lung cancer research programme, launched by the Irish Cancer Society and Beaumont RCSI Cancer Centre has become the largest single investment in lung cancer in Ireland's history. Speaking to Shane this morning on the show was Michael McCarthy, Consultant Medical Oncologist and Secretary of the Irish society of Medical Oncology.
A €4.9 million lung cancer research programme, launched by the Irish Cancer Society and Beaumont RCSI Cancer Centre has become the largest single investment in lung cancer in Ireland's history. Speaking to Shane this morning on the show was Michael McCarthy, Consultant Medical Oncologist and Secretary of the Irish society of Medical Oncology.
The European Union is urging member countries to ban smoking and vaping in outdoor spaces like playgrounds, bus stops, and café terraces as part of its 'Beating Cancer Plan. The aim is to protect citizens from second-hand smoke.However, Irish Minister Jack Chambers has expressed doubts, saying he's 'not sure how workable' the proposal is.Joining Kieran to discuss is John Crowne, Professor and Consultant Medical Oncologist at St Vincent's Hospital Group and Dr Garrett McGovern, Medical Director of Priority Medical Clinic and GP specialising in Addiction.
People with cancer are waiting too long for treatment in Ireland. That's the view of Dr Michael McCarthy, Consultant Medical Oncologist, Secretary of the Irish Society of Medical Oncology who spoke to Newstalk Breakfast this morning.
People with cancer are waiting too long for treatment in Ireland. That's the view of Dr Michael McCarthy, Consultant Medical Oncologist, Secretary of the Irish Society of Medical Oncology who spoke to Newstalk Breakfast this morning.
The word ‘legend' gets bandied around a lot these days, but former footy superstar Ken Hunter most certainly IS a bona fide legend, and he's our special guest on the Food Bytes podcast this week. Skilful, feared and fearless, the Carlton great was known for his spectacular marks, and for going in where angels fear to tread! We talk to Ken about his playing days, how Aussie Rules footy has changed, his work in the mental health space with the Fifth Quarter Foundation, and why Italian food is always on the menu at his house! And in the Friday Food Poll this week … the beef burger and the vegie burger go head to head. Our extra seat at the Food Bytes table is Dr Anthony Dowling, Associate Professor of Medicine at University of Melbourne and a Consultant Medical Oncologist at St Vincent's Public Hospital Melbourne talking about the important work he is doing in cancer treatment and the role the wig and headwear studio has in patient wellbeing. Here is the link to donate to he St. Vincent's Public Hospital Wig and Headware Studio. https://www.stvfoundation.org.au/donate/wigs Presented by Sarah Patterson & Kevin Hillier Broadcast each Sunday on the ACE Radio Network - https://aceradio.com.au/ Catch us also on: The Buzzz - Melbourne's Home of Classic Hits - thebuzzz.com.au Radio 2DD - Easy Listening - On Line - https://www.2dd.online/ Radio Bayside - Stream.radiobayside.com Follow us on Facebook...https://www.facebook.com/foodbyteswithsarahpatterson/ Twitter & Instagram - @sarahfoodbytes Post-production by Chris Gates for Howdy Partners Media | www.howdypartnersmedia.com.au/podcasts © 2024See omnystudio.com/listener for privacy information.
There has been major news in the world of medicine.The world's first vaccine for treating Melanoma, a common type of skin cancer, has shown extremely impressive results in trials. Joining Kieran to discuss the breakthrough and the development of cancer treatment is John Crowne, Professor and Consultant Medical Oncologist, St Vincent's Hospital Group.
Prof Janice Walshe, Consultant Medical Oncologist, St Vincent's University Hospital
Today marks the start of 'Bowel Cancer Awareness month'. Joining Pat to discuss the signs and symptoms of bowel cancer was Dr Grainne O'Kane, Consultant Medical Oncologist, Trinity St. James's Cancer Research Institute and also Deirdre Dee Fleming, a Stage 4 Bowel Cancer Survivor.
Professor Janice Walshe is a Consultant Medical Oncologist at St Vincent's hospital specialising in breast cancer. Described as a superstar in the oncology day ward, Professor Walshe tells Sean about the relationship she builds with her patients and the importance of being honest and empathetic in her approach.
Professor Janice Walshe, Consultant Medical Oncologist, St Vincent's Hospital
Today, we're joined by Dr. Aydah Al Awadhi, Consultant Medical Oncologist and Chairperson of the breast cancer working group under the Emirates Oncology Society... She's answering your key questions regarding breast cancer. Welcome to the show
In episode 2 of the ISGO podcast, we speak with Dr. Dearbhaile Collins, Consultant Medical Oncologist, who explains medications known as PARP inhibitors, how they work and who they're suitable for. We then speak with Jenny, a patient living with Ovarian Cancer, and who takes a PARP inhibitor medication.
John Duddy, Spinal surgery fellow, Walton Centre in Liverpool and Dr Toby Gilbert, Divisional Director for medicine for Northern Adelaide Local Health Network, Australia, Roisin O'Cearbhaill, Consultant Medical Oncologist, Memorial Sloan Kettering, New York.
Professor Ray McDermott, Consultant Medical Oncologist, explains the situation
Professor Janice Walsh, Consultant Medical Oncologist, St Vincent's Hospital
On today's episode, meet Dr. Sanjay Popat. Dr. Popat has both a private and an NHS practice at The Royal Marsden. He is a Consultant Medical Oncologist at The Royal Marsden, Professor of Thoracic Oncology at the Institute of Cancer Research and is an internationally recognized expert in the treatment of lung cancer. Sanjay qualified from Guy's and St Thomas' Hospitals in 1994, completed general medical training at the Royal Brompton, and the Hammersmith Hospital, and medical oncology training at the Royal Marsden Hospital. He was awarded a PhD in Molecular Genetics in 2002. He's a strong advocate for patient education and support and is passionate about precision medicine.
Angela George, Consultant Medical Oncologist, Consultant in Oncogenetics, and Clinical Director of Genomics, The Royal Marsden Hospital, London, UK, joins Jonathan to discuss the importance of personalised cancer treatment for patients. George explains her specific interest in germline and somatic mutations in cancer, the hereditary and genetic links in different cancer types, and her focus on genomics research to improve outcomes for patients during and post-treatment.
On January 26, 2023, the US FDA granted approval of pembrolizumab, an anti-PD-1 antibody, as an adjuvant therapy for patients with resected NSCLC. In this episode of Lung Cancer Considered host Dr. Stephen Liu leads a discussion on this approval with two thoracic medical oncologists with extensive expertise in this space: Dr. Jamie Chaft, an Associate Attending at Memorial Sloan Kettering Cancer Center, where she is the Director of Early Stage Lung Cancer Research, chair of the adjuvant nivolumab trial within the ALCHEMIST program and heavily involved in perioperative systemic therapy studies. Dr. Mary O'Brien, Professor and Consultant Medical Oncologist at the Royal Marsden in Surrey, Head of the Lung Unit, and chair of the EORTC Lung Cancer Group. She was one of the investigators on the KEYNOTE 091 trial which provided key data that lead to this approval.
Professor Seamus O'Reilly, Consultant Medical Oncologist, on a wave of delayed cancer diagnoses.
Doctor Caoimhe Hartly speaks to Professor Conleth Murphy about the area of Oncology and the effects of using HRT. Conleth took up his position as a Consultant Medical Oncologist at the Bon Secours Health System in Cork in August 2010. His treatment focus includes breast cancer, gynecologic malignancies such as ovarian cancer and urologic malignancies such as prostate, kidney and bladder cancers. He is passionate about medical education and is a Senior Lecturer in Clinical Education with UCC. He is an active member of Cancer Trials Ireland and has acted as national lead investigator for several key clinical trials for cancer patients. With the clinical trial team at Bon Secours Cork, Conleth has opened a number of important trials which seek to build on current treatments to improve the outlook for patients with cancer. Learn More About Yourself Our information hub is bursting with facts about your menstrual cycle, menopause journey, and the research we've done over the years to make Key a straight-forward solution for women. Unlock your best self with daily wellness designed for women! Click here to visit our information hub >> learn.keyforher.com About Key for Her Donna & Renée are the co-founders of Key For Her. They set up their company Key For Her to empower and support women around the menstrual cycle, perimenopause and general women's health in this series, the two women will share their own journeys and all elements of their empowering business, while also speaking with resident Key For Her podcast doctor, Dr. Caoimhe Hartley, and a number of other people who are also de-stigmatising and opening up positive conversations around women's health. Connect with us! Website | keyforher.com Facebook | www.facebook.com/keyforher Instagram | @keyforher Twitter | @keyforher Tiktok | @keyforher LinkedIn | FemTech Healthcare Pinterest | www.pinterest.com/keyforher
Dr Axel Walther, Consultant Medical Oncologist at Bristol Haematology and Oncology Centre, UK, disucsses how he treats people with recurrent ovarian cancer. He also recaps on the use of PARP inhibitors in initial advanced ovarian cancer. He is a great font of knowledge on ovarian cancer and the trials that underpin the treatment options, so this podcast will be a very useful overview of the UK current treatment paradigms at registrar level. Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK.
Professor Janice Walshe, Consultant Medical Oncologist, St Vincent's Hospital
US President Joe Biden is seeking to “end cancer as we know it” - as he has announced a new programme that will look to reduce the incidence of cancer by at least 50%, over the next 25 years. Professor Seamus O'Reilly, Consultant Medical Oncologist in Cork University Hospital spoke to Newstalk Breakfast this morning.
US President Joe Biden is seeking to “end cancer as we know it” - as he has announced a new programme that will look to reduce the incidence of cancer by at least 50%, over the next 25 years. Professor Seamus O'Reilly, Consultant Medical Oncologist in Cork University Hospital spoke to Newstalk Breakfast this morning.
Dr Axel Walter, Consultant Medical Oncologist at Bristol Haematology and Oncology Center, kicks off the series about how to manage ovarian cancer. He discusses in depth the staging system and how women with initial ovarian cancer should be treated, including both those with stage 1 and stage 3 disease. This includes an explanation regarding BRCA and HRD (homologous recombination deficiency) testing and treatment with adjuvant PARP inhibitors. Your host is Dr Alison Cameron, Bristol, UK.
Dr Abdul Rahman Al Kinge, Consultant Medical Oncologist from Fakeeh University Hospital joined TSB. Kitch and Neeil discussed with Dr Abdul: The Importance of being proactive about your healthTesting for cancer methodsMyths about cancer treatments and diagnosisThe most common forms of cancer in the UAEThe role of family and friends as the support networkwww.fakeeh.care Hosted on Acast. See acast.com/privacy for more information.
More workforce is needed across the health services to cope with the growing population but where will they all come from? We debate with Dr. Conor Keegan Senior Research Officer, ESRI, and John Crowne Professor and Consultant Medical Oncologist, St Vincent's Hospital Group.
On this episode of the Newson Health Menopause Society podcast, host Lauren Redfern is joined by Consultant Medical Oncologist Rebecca Bowen. Together, Lauren and Rebecca discuss the decision-making process involved when patients diagnosed with breast and gynaecological cancers are considering using HRT. Rebecca helps to explain the factors that both patients and clinicians need to consider when approaching treatment and helps to dispel common misconceptions surrounding cancer risk. Rebecca helps to clarify that whilst some patients may not realistically be able to use HRT due to their particular diagnosis, each patient is different and should be treated as an individual. She highlights the importance of integrated approaches to clinical care, outlining how communication between Oncologists, General Practitioners and Menopause Specialists, can help to empower patients to make informed decisions about the best course of treatment that is right for them. Rebecca Bowen is a Consultant Medical Oncologist specialising in breast and gynaecological cancers. She works at one of the very few oncology clinics in the country that integrates menopausal treatment into their care.
In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Susana Banerjee to discuss SOLO1. Dr. Banerjee is a Consultant Medical Oncologist and Research Lead for the Gynaecology Unit. She is also Reader in Women's Cancers at the Institute of Cancer Research. Dr Banerjee specialises in ovarian cancer and the systemic treatment of endometrial and cervical cancers. Highlights: - This report is the longest follow-up period for a PARP inhibitor in the newly diagnosed advanced ovarian cancer. - The present analysis shows a PFS benefit that is sustained for several years following completion of 2 years of maintenance olaparib. - PFS benefit was consistent irrespective of higher or lower clinical risk or BRCA1 or BRCA2 mutation. - SOLO1 is the first to report longer-term follow-up for safety in patients with newly diagnosed ovarian cancer receiving a PARPi as maintenance treatment. - The safety profile for patients in the maintenance olaparib remained consistent with that reported previously, with no new safety signals. Importantly, no additional cases of MDS or AML were reported.
We hear why it's vitally important that more cancer patients consider taking part in clinical trials with Professor Ray McDermott, Consultant Medical Oncologist and Clinical Lead at Cancer Trials Ireland. Listen and subscribe to The Pat Kenny Show on Apple Podcasts, Google Podcasts and Spotify. Download, listen and subscribe on the Newstalk App. You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.
‘Living with Ovarian Cancer Podcast' is full of inspiring stories told by people who are living with or have a connection with Ovarian Cancer. Each person's story is a gift; unique and is told from the heart in their own words. I am your host, Diane Evans-Wood. Please subscribe to the Podcast and leave a 5* review so that the show becomes more visible to listeners. In this episode I talk to Dr Clare Green who is my Consultant Medical Oncologist. Clare kindly agreed to be a guest for this episode not only on her day off but also on her Birthday. We covered a lot in this episode from what made Clare decide to be a Doctor, what her medical training was like, symptoms and management of Ovarian Cancer to her adventures to Africa on a secondment. It was so interesting to talk to Clare to gain some insight into her world as a Medical Oncology Consultant. I am extremely lucky to have such a dedicated and grounded Oncologist on my side. Thank you so much for listening to ‘Living with Ovarian Cancer'. If you want to get in touch with me or you would like to tell your own story on this Podcast about living with Ovarian Cancer, please email diane.evanswood@gmail.com You can find more information about me on my website by following this link: https://dianeevanswood.wordpress.com My sincere gratitude to Gary and Ruthie Colcombe who continue to carry out all the editing and uploading of each episode of this Podcast. I couldn't have managed without them! You can find their Podcasts here http://celticmythpodshow.comand https://inbedwithadruid.com Intro and outro music is called ‘Waltz for the little mermaid' by Meidi Goh. To read more about Meidi please follow this link http://meidigoh.com Before you go, please don't forget to click ‘subscribe' to this Podcast so that you don't miss future episodes and also if you could leave a rating, I'd be very grateful. Disclaimer: Each story in this Podcast is unique to the woman who is telling it. The content of each episode and the views expressed are not meant to be a substitute for medical advice or intervention. You will hear stories of women who sought alternative therapies, integrated oncology services or even choosing to decline treatment options. However, this is their story, and I am not advocating that you follow the path of any one woman who features in the podcast. If you have a diagnosis of Ovarian Cancer, please make sure that you discuss anything that is going to affect your treatment or wellbeing with your own Medical team. You are unique and so what's right for one woman may not be right for you!
Dr. Conleth Murphy is a Podcaster and Consultant Medical Oncologist based in the Bons Secours Hospital in Cork, Ireland. He talks about gynecologic, urologic malignancies, how patient care is developing, and his story behind starting The Cure Podcast. Know more about Dr. Conleth Murphy: Twitter: https://twitter.com/conlethmurphy Listen to The Cure Podcast: Spotify: is.gd/Hn5Jsp Apple podcast: is.gd/tqxMWz For inquiries, contact us at info@oncoassist.com Let's connect: Website: www.oncoassist.com Twitter: https://twitter.com/oncoassist LinkedIn: https://www.linkedin.com/showcase/oncoassist Instagram: https://www.instagram.com/oncoassist/ Facebook: https://www.facebook.com/ONCOassist
November is pancreatic cancer awareness month. This podcast episode serves to provide educational information to a global audience. #pancreaticcancer #cancer Our guest: Dr. Chinenye Iwuji is a Consultant Medical Oncologist, who worked at University Hospitals of Leicester NHS Trust until her move to Lakeshore Cancer Centre in Nigeria. She qualified from Southampton Medical School and holds a degree in Physiology from University of Dundee. Her post-graduate qualifications include a Master's Degree in Oncology (University of Nottingham) and a PhD (University of Leicester), following her research investigating the use of curcumin in the treatment of colorectal cancer. Dr. Iwuji treats all solid tumours and has a specialist interest in palliative care. To find out more about the Cancer program visit Instagram @lcccares --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/health4naija/support
During the COVID-19 pandemic, the EU proposal for a European Health Union has become a high priority, while the area of healthcare remains the sole domain of national governments. 'Europe's Beating Cancer Plan' is the EU's latest effort to mobilise the collective power of its Member States in new areas of healthcare policy. The plan contains concrete, ambitious actions that will support, coordinate, and complement Member States' national policies in the area of cancer prevention, treatment and care. It also recognises the scope of the challenge and addresses research and innovation. This expert panel provides policy, clinical, patient and industry perspectives on the Europe's Beating Cancer Plan and discusses how it could shape the future of national cancer care and policy in Ireland. The panel also compares Ireland's performance to that of its European counterparts in terms of cancer care outcomes and the lessons to be learned to improve care for patients in Ireland. Speakers include: Matthias Schuppe, Project Leader for the Cancer Task Force, DG SANTE, European Commission Anouk de Vroey, Senior Director of Government Affairs & Policy, Johnson & Johnson Professor John Crown, Professor and Consultant Medical Oncologist, St Vincent's Private Hospital Rachel Morrogh, Executive Director of Advocacy and External Relations, Irish Cancer Society The event will be moderated by Terence O'Rourke, IIEA Board Member and Chairman of Enterprise Ireland and of ESB. About the Speakers: Matthias Schuppe is the Project Leader of the Cancer Task Force in DG SANTE at the European Commission. Mr Schuppe has over 8 years experience in policy and project management at the Commission. Previously, he worked for the European Public Health Alliance and the European Health Forum Gastein. He holds an MSc in Health Services and Systems Research from the London School of Hygiene and Tropical Medicine at the University of London. Anouk de Vroey currently leads the EMEA Government Affairs & Policy team for the pharmaceutical division of Johnson & Johnson – Janssen pharmaceuticals. Ms de Vroey is responsible for managing the implementation of advanced purchase agreements in EMEA of Janssen's COVID19 vaccine. She is involved in several industry platforms to support a strong climate of biopharmaceutical innovation. Throughout her 22 year-career in the pharmaceutical industry, Ms de Vroey has been involved in initiatives to accelerate the European Market Authorization procedures both at the EU Commission and the European Federation of the Pharmaceutical Industry. John Crown is a Professor and consultant medical oncologist at St. Vincent's Private Hosptial. He received his medical training at University College Dublin and the State University of New York. He completed his fellowship training in oncology at Mount Sinai Medical Centre and in haematology/oncology at Memorial Sloan Kettering Cancer Centre before joining St. Vincent's University Hospital in 1993. Rachel Morrogh is the Director of Advocacy and External Relations at the Irish Cancer Society since April 2020 and previously served as the Head of the Advocacy Department from 2018 to 2020. She is an experienced campaigner with extensive advocacy and policy experience having worked in the Oireachtas, large multinationals, public affairs consultancy and the non-profit sector for more than 15 years.
Could 'Europe's Beating Cancer Plan' have a positive impact on Irish cancer care? To discuss with Pat this morning was Prof. John Crown, Professor and Consultant Medical Oncologist, St Vincent's Private Hospital and also Rachel Morrogh, Executive Director of Advocacy and External Relations, Irish Cancer Society. Listen and subscribe to The Pat Kenny Show on Apple Podcasts, Google Podcasts and Spotify. Download, listen and subscribe on the Newstalk App. You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.
Dr Janice Walshe, Consultant Medical Oncologist at St. Vincent's Hospital & Tallaght Hospital.
This week we are joined by Dr Jarushka Naidoo, Consultant Medical Oncologist at Beaumont Hospital and Chair of the Lung Cancer Group at Cancer Trials Ireland to discuss Lung Cancer.
Today's Oncology Spotlight is with Dr. Giuseppe Banna, a 46-year old Consultant Medical Oncologist, and father of 2 daughters. His clinical and scientific experience has been mostly focused on thoracic and urology cancer and prognostic and predictive biomarkers for systemic cancer treatments, particularly for immunotherapy. He works at the Department of Oncology of Portsmouth Hospitals University NHS Trust in the UK and his subspecialties are Lung and Urology. He's Italian and moved to the UK two years ago. Currently, he's working with his European colleagues on predictive models of efficacy and toxicity of immunotherapy based on immune-inflammatory biomarkers and artificial intelligence. He has a soft spot for the academy and clinical and translational research. In 2017, he was entitled with an Italian qualification to be an Associate Professor. He promoted translational and clinical research trials and joined national and European cancer research networks. He's the coordinator of the Italian Association of Medical Oncology (AIOM), Italian Germ Cell Cancer Group (IGG) guidelines for testicular germ cell tumors, and also a member of the British Thoracic Oncology Group (BTOG), the International Society of Geriatric Oncology (SIOG), the Italian Urologic Meet-Uro and the EORTC Lung and Urology Cancer Group. In 2011 he co-founded a non-profit organization "Medicare Onlus - You Make It Real" to promote initiatives regarding the primary and secondary prevention of cancer and support cancer patients and their families in the South of Italy. We at ONCOassist had a chance to speak with him about his work and its impact on his life both professionally and personally. His responses during the interview offer meaningful insight into the life of an Oncologist who's dedicated to providing unparalleled care to his patients. 00:00 Introduction 02:26 Medicare Onlus - You Make It Real 04:25 What would you say excites you the most in your industry? 06:33 Mentions: Alfredo Addeo & Fabio Gomes 09:22 How did you originally find out about ONCOassist and why did you decide to install the app? 16:26 How do you use ONCOassist? 18:02 In your perspective, what health industry problem is ONCOassist well placed to solve? 19:20 Why did you decide to pursue a career in medicine, specifically Oncology? 22:22 What are some of your biggest challenges day-to-day as an Oncologist? 25:22 A positive impact of COVID-19 is the adoption of digital health, can you give us a few examples of your experience around this? 27:29 Mention: ONCOalert & Gil Morgan 29:27 For any patients and caregivers reading this, what are your tips on navigating cancer care? ✅ Know more about: Medicare Onclus: https://www.medicareonlus.com Dr. Giuseppe Banna: https://www.twitter.com/gbanna74 ✅ For inquiries, contact us at info@oncoassist.com ✅ Let's connect: Website: www.oncoassist.com Twitter: https://twitter.com/oncoassist LinkedIn: https://www.linkedin.com/showcase/onc... Instagram:https://www.instagram.com/oncoassist/ Facebook: https://www.facebook.com/ONCOassist/
Professor Seamus O'Reilly, Consultant Medical Oncologist at Cork University Hospital and the Mercy University Hospital
Dr Miriam O'Connor, Consultant Medical Oncologist at University Hospital Waterford; Prof. Ciaran Martin, Cyber Security; and Kevin Collier, NBC News reporter focusing on cyber security, on the HSE's cyber attack
This week, Jonathan sits down with Dr Caroline Michie, Consultant Medical Oncologist, Honorary Clinical Senior Lecturer, Edinburgh Cancer Centre & University of Edinburgh to discuss the challenges of cancer care during and post-pandemic, as well as regional differences in healthcare.
Joe chats to Prof Linda Coate, Consultant Medical Oncologist, University Hospital Limerick and Limerick patient Peter Mcnamara about cancer clinical trials and why patients should consider them See acast.com/privacy for privacy and opt-out information.
Professor Seamus O'Reilly, Consultant Medical Oncologist at Cork University Hospital, appeals to hospitals, healthcare organisations and medical suppliers to donate respiratory equipment which will be sent to India.
Dr Kim Linton presents a podcast on the BSH Guideline on the investigation and management of follicular lymphoma. Follicular lymphoma (FL) is a heterogeneous disease. For many it is experienced as a chronic, relapsing, indolent condition with long overall survival (OS). Most people affected have advanced disease at presentation; symptoms may include B symptoms (i.e. fever, night sweats and weight loss), fatigue and the local mass effect of lymph node enlargement. However, many people are asymptomatic at presentation. Some people are observed without treatment according to a ‘watch and wait' policy (see section Management of patients with newly diagnosed FL). In contrast to this, over a period of many years, 20–30% of patients will die from refractory FL or following transformation of their disease to high‐grade lymphoma.1 Prognostic indices may help discriminate between risk groups (see section Prognostic factors in FL). Dr Linton discusses the guidelines four main focus areas: 1) Important changes on the use of PET scanning. 2) Advances in the upfront management of patients with asymptomatic and symptomatic advance stage disease. 3) High risk disease in high grade transformation. 4) Advances in the management of relapse with some horizon scanning of promising drugs in development Dr Kim Linton is Consultant Medical Oncologist at Christie NHS Foundation Trust and Clinical Senior Lecturer at the University of Manchester.
Doctor Megan Greally is a Consultant Medical Oncologist at the Mater Private Hospital, Dublin. Dr. Megan Greally graduated, MB BCh BAO, from the National University of Ireland, Galway in 2008. She obtained membership of the Royal College of Physicians of Ireland (MRCPI) in 2011 and completed Higher Specialist Training in Medical Oncology in 2017. During her training she obtained a diploma in Clinical Education at the National University of Ireland, Galway. In 2016 she was the recipient of an ISMO visiting scholar fellowship at Memorial Sloan Kettering Cancer Centre.
Dr Naureen Starling is a Consultant Medical Oncologist at The Royal Marsden hospital in London, specialising in the treatment of gastrointestinal cancers. She is better known to listeners as Steve Hewlett's doctor. She explained to Eddie Mair that one thing she has learnt whilst treating Steve was that clear communication was vital. "I think it's often good for me and my colleagues just to step back and think actually am I communicating this clearly in a way the patient can understand."
© 2020-2025 Ivy Podcast Discovery LLC
